Galmed Pharmaceuticals Ltd (GLMD)

NASDAQ
0.510
-0.015(-2.87%)
After Hours
0.510
0.000(0.02%)
- Real-time Data
  • Volume:
    279,788
  • Day's Range:
    0.510 - 0.531
  • 52 wk Range:
    0.500 - 4.080

GLMD Overview

Prev. Close
0.525
Day's Range
0.51-0.531
Revenue
-
Open
0.525
52 wk Range
0.5-4.08
EPS
-1.18
Volume
279,788
Market Cap
12.8M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
98,573
P/E Ratio
-
Beta
1.79
1-Year Change
-80.6%
Shares Outstanding
25,088,414
Next Earnings Date
Aug 04, 2022
What is your sentiment on Galmed Pharma?
or
Market is currently closed. Voting is open during market hours.

Galmed Pharmaceuticals Ltd News

Galmed Pharmaceuticals Ltd Analysis

Galmed Pharmaceuticals Ltd Company Profile

Galmed Pharmaceuticals Ltd Company Profile

Employees
21

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. It has a research agreement with Gannex Pharma Co., Ltd. to develop a combination therapy of ASC41 (THR-beta agonist) and Aramchol (SCD 1 inhibitor) for the treatment of NASH; a research and development collaboration agreement with MyBiotics Pharma Ltd. to identify the selected microbiome repertoire associated with the response to Aramchol; and a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Tel Aviv, Israel.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • Why the drop? Do they have anything in the pipeline?
    1
    • They have
      0
  • will it go up soon or back down first?
    0
    • Who knows?
      0
  • I love glmd stock and its people.theres a real very real vision hiding there and yields too. .
    0
    • Glmd is like a little green plant.give it strength so it can stand up and walks by its own!!
      0
      • I believe glmd and despise those who trhow the stock panickly...
        0
        • I believe in glmd because it has a vision. Seeking alfa critisized it vicously and twisted wrongly the wonderfull results of the trial of armacholl. I salute to the wonderfull pannel of ceo and directors of glmd.
          0
          • ITS MUCH BETTER IF HE HAD BOUGHT MISERABE TEVA....
            0
            • please mr FROST-STOP MANIPULATE OPK STOCK!
              0
              • ITS A PITY THEY LET MR FROST MANIPULATE OPK STOCK. IN MY VIEW ITS UNETHICHAL AND ON THE SIDELINES OF A CRIMINAL OFFENCE.r. r. MR FROST-DONT MANIPULATE OUR STOCK MARKET. WE DONT NEED YOU!
                0